Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Heron Neutron Medical Corp. has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to examiner KYLE A PURDY, who is the only distinct examiner currently handling the company's pending cases. This indicates a focused prosecution effort where a single examiner is responsible for the company's current interaction with the USPTO.
The portfolio's activity is concentrated in 1 distinct art unit. KYLE A PURDY is identified as the busiest examiner for the company, overseeing 1 pending office action. Since there is only 1 pending action and 1 distinct examiner, the entire prosecution workload for this portfolio is managed by this individual. This concentration within the Biotechnology & Pharmaceuticals area suggests a specific technical application currently under review.
Practitioners should note that the company's current prosecution success relies on the relationship with a single examiner in a single art unit. With only 1 pending office action, there is no broader portfolio activity to provide comparative data on examiner behavior. The strategy must be tailored specifically to the requirements of KYLE A PURDY and the norms of the individual art unit involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PURDY, KYLE A | 1 | 41.0% | +35.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18442595 | LYOPHILIZED POWDER CONTAINING BORON COMPLEX AND METHOD OF FORMING THE SAME | PURDY, KYLE A | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18442595 | LYOPHILIZED POWDER CONTAINING BORON COMPLEX AND METHOD OF FORMING THE SAME | PURDY, KYLE A | 1611 | §103 | Non-Final OA | — | Pending | Feb 15, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial